You are here

Clinical Trials: Cord Blood


Body: Condition:   Bronchopulmonary Dysplasia
Interventions:   Biological: Pneumostem®;   Biological: normal saline
Sponsor:   Medipost Co Ltd.
Recruiting - verified April 2017
Body: Condition:   Hypoplastic Left Heart Syndrome
Intervention:   Biological: autologous cell-based delivery
Sponsors:   Timothy J. Nelson;   University of Oklahoma;   Children's Hospital of Philadelphia
Recruiting - verified June 2017
Body: Conditions:   GATA2;   Immunodeficiency;   MDS
Interventions:   Procedure: Allogeneic HSC;   Drug: Busulfan Test dose;   Drug: Fludarabine(Fludara, Berlex Laboratories);   Drug: Busulfan (Busulfex);   Drug: Cyclophosphamide(CTX, Cytoxan);   Procedure: Total Body Irradiation (TBI);   Drug: Equine Anti-Thymocyte Globulin
Sponsor:   National Cancer Institute (NCI)
Recruiting - verified January 31, 2017
Body: Conditions:   Aplastic Anemia;   Leukemia;   Myelodysplastic Syndrome (MDS);   Lymphoma
Intervention:   Procedure: Cord Blood Units
Sponsors:   National Heart, Lung, and Blood Institute (NHLBI);   National Cancer Institute (NCI);   National Institute of Allergy and Infectious Diseases (NIAID);   National Cord Blood Program, New York Blood Center
Recruiting - verified January 12, 2017
Body: Condition:   Hypoplastic Left Heart Syndrome (HLHS)
Intervention:   Other: Collection of umbilical cord blood
Sponsor:   Mayo Clinic
Body: Condition:   Bronchopulmonary Dysplasia
Interventions:   Biological: Pneumostem®;   Other: Normal Saline
Sponsor:   Medipost Co Ltd.
Completed - verified April 2017
Body: Condition:   Leukemia
Interventions:   Drug: Busulfan;   Drug: Fludarabine;   Procedure: Alloreactive NK infusion;   Drug: Interleukin-2;   Procedure: Stem Cell Infusion;   Drug: G-CSF;   Drug: Tacrolimus;   Drug: Methotrexate
Sponsors:   M.D. Anderson Cancer Center;   Cancer Prevention Research Institute of Texas;   CML Program Project Grant
Recruiting - verified June 2017
Body: Conditions:   Hematological Malignancies;   Acute Lymphoblastic Leukemia (ALL);   Acute Myeloid Leukemia (AML);   Myelodysplastic Syndrome (MDS)
Intervention:   Drug: NiCord®
Sponsor:   Gamida Cell ltd
Recruiting - verified May 2017
Body: Condition:   Acute Leukemia
Intervention:   Procedure: allogeneic transplant
Sponsor:   Gruppo Italiano Trapianto di Midollo Osseo
Completed - verified August 2017
Body: Condition:   Hematologic Malignancies
Interventions:   Device: CliniMACS® CD34 Reagent System;   Drug: Fludarabine;   Drug: Melphalan;   Drug: Rabbit ATG (rATG)
Sponsor:   Weill Medical College of Cornell University
Body: Conditions:   Chronic Myelogenous Leukemia (CML);   Acute Myelogenous Leukemia (AML);   Myelodysplastic Syndrome;   Multiple Myeloma;   Hodgkin Lymphoma;   Non-Hodgkin Lymphoma;   Chronic Lymphocytic Leukemia (CLL);   Acute Lymphocytic Leukemia (ALL);   Severe Aplastic Anemia
Intervention:   Genetic: umbilical cord blood (UCB)
Sponsor:   West Virginia University
Body: Conditions:   Acute Myelogenous Leukemia;   Myelodysplastic Syndrome;   Acute Lymphocytic Leukemia;   Hodgkin's Lymphoma;   Non-Hodgkin's Lymphoma
Interventions:   Device: CliniMACS® CD34 Reagent System;   Drug: Fludarabine;   Drug: Melphalan;   Drug: Rabbit ATG;   Procedure: Double Umbilical Cord Blood Transplantation;   Procedure: Haplo-Identical Cord Transplantation
Sponsor:   Weill Medical College of Cornell University
Terminated - verified August 2017
Body: Condition:   Degeneration Articular Cartilage Knee
Intervention:   Biological: CARTISTEM®
Sponsor:   Medipost Co Ltd.
Active, not recruiting - verified April 2017
Body: Condition:   Myeloma
Interventions:   Drug: Lenalidomide;   Drug: Melphalan;   Procedure: NK Cell Infusion;   Procedure: Stem Cell Infusion;   Drug: G-CSF;   Drug: Elotuzumab;   Drug: Dexamethasone
Sponsors:   M.D. Anderson Cancer Center;   Celgene
Recruiting - verified June 2017
Body: Condition:   Hematopoietic Stem Cell Transplantation
Intervention:   Procedure: Intrabone infusion of umbilical cord blood stem cells
Sponsors:   Henrique Bittencourt, MD, PhD;   Michel Duval, MD;   Pierre Teira, MD;   Sonia Cellot, MD, PhD;   Isabelle Louis, PhD;   Elie Haddad, MD, PhD;   Marie-France Vachon, MScN;   Marion Cortier, PhD